eXoZymes, Inc. (EXOZ)

CIK 0002010788 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statements of Changes In Equity (unaudited)
—
Consolidated Statements of Changes In Stockholders' Equity (deficit)
—
Consolidated Statements of Operations (P)
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Deficit (unaudited)
—
Notes
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Earnings Per Share
Employee Benefit Plans
Equity
Equity and Non-controlling Interests
—
Exclusive License Agreement (exozymes)
Exclusive License Agreement (invizyne)
—
Income Taxes
Insider Trading Arrangements
—
Leases
Organization and Description of Business
Pay Vs Performance Disclosure
—
Simple Agreement For Future Equity (safe)
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies